Kyung Nam Pharm Co.,Ltd. announced a private placement of series 6 unregistered coupon nonguaranteed private convertible bond for gross proceeds of KRW 8,000,000,000 on November 30, 2021. The transaction will include participation from Metaplex Co., Ltd. for KRW 5,000,000,000, Withwin-Y Investment Association 3 for KRW 2,500,000,000, and Geo-One Co., Ltd. for KRW 500,000,000. The bonds carry rate of surface interest rate and maturity rate of 4% per annum. The bonds will mature on December 10, 2024. The bonds are fully convertible into 1,500,938 shares of the company at a conversion price of KRW 5,330 per share. The conversion period will start from December 10, 2022 and ends on December 2, 2024. The transaction is expected to close on December 10, 2021. The transaction has been approved by the board of directors of the company.